Back
Cincinnati Financial Vs. Rhythm Pharmaceuticals Industry Stock Comparison
Sell
44
CINF
Cincinnati Financial
Last Price:
136.17
Seasonality Move:
2.81%
Buy
57
RYTM
Rhythm Pharmaceuticals
Last Price:
53.08
Seasonality Move:
11.04%
Sell
44
Cincinnati Financial (CINF)
is a Sell
Is Cincinnati Financial a Buy, Sell or Hold?
- The current Cincinnati Financial [CINF] share price is $137.18. The Score for CINF is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- CINF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
57
Rhythm Pharmaceuticals (RYTM)
is a Buy
Is Rhythm Pharmaceuticals a Buy, Sell or Hold?
- The current Rhythm Pharmaceuticals [RYTM] share price is $49.52. The Score for RYTM is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- RYTM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CINF Stock Price Chart
What is Cincinnati Financial's stock price today?
-
The Cincinnati Financial share price today is $137.18
The current trend is moderately bullish and CINF is experiencing slight buying pressure.
RYTM Stock Price Chart
What is Rhythm Pharmaceuticals's stock price today?
-
The Rhythm Pharmaceuticals share price today is $49.52
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing slight selling pressure.
CINF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.21 | Buy |
Relative Strength Index (14 RSI): | 62.5 | Buy |
Chaikin Money Flow: | 271688 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (130.57 - 136.81) | Buy |
Bollinger Bands (100): | (115.01 - 130.39) | Buy |
RYTM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.91 | Buy |
Relative Strength Index (14 RSI): | 57.18 | Buy |
Chaikin Money Flow: | -131805 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (45.52 - 49.1) | Buy |
Bollinger Bands (100): | (39.32 - 48.12) | Buy |
CINF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 136.09 | Buy |
20-day SMA: | 134.8 | Buy |
50-day SMA: | 128.99 | Buy |
200-day SMA: | 117.26 | Buy |
8-day EMA: | 136.04 | Buy |
20-day EMA: | 134.45 | Buy |
50-day EMA: | 129.81 | Buy |
200-day EMA: | 119.35 | Buy |
RYTM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 49.38 | Buy |
20-day SMA: | 47.68 | Buy |
50-day SMA: | 47.5 | Buy |
200-day SMA: | 43.19 | Buy |
8-day EMA: | 49.08 | Buy |
20-day EMA: | 48.09 | Buy |
50-day EMA: | 46.65 | Buy |
200-day EMA: | 41.27 | Buy |
Cincinnati Financial Earnings Growth & CINF Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.24 per share, an increase next quarter of $0.20 per share, an increase this year of $0.91 per share, and an increase next year of $0.57 per share.
Rhythm Pharmaceuticals Earnings Growth & RYTM Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.11 per share, an increase next quarter of $0.24 per share, a decrease this year of $1.32 per share, and an increase next year of $1.68 per share.
Cincinnati Financial Technical Analysis
Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Rhythm Pharmaceuticals Technical Analysis
Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |